1. Alexithymia is associated with increased all-cause mortality risk in men, but not in women: A 10-year follow-up study
- Author
-
Henry Völzke, Jan Terock, Matthias Nauck, Deborah Janowitz, Hans J. Grabe, and Johanna Klinger-König
- Subjects
Adult ,Male ,Alexithymia ,media_common.quotation_subject ,Sexism ,Large population ,Cohort Studies ,03 medical and health sciences ,0302 clinical medicine ,Surveys and Questionnaires ,Sex differences ,Medicine ,Humans ,Affective Symptoms ,030212 general & internal medicine ,ddc:610 ,Socioeconomic status ,media_common ,business.industry ,10 year follow up ,General population ,Sociodemographic factors ,Middle Aged ,medicine.disease ,All-cause mortality ,mortality [Affective Symptoms] ,Psychiatry and Mental health ,Clinical Psychology ,Feeling ,Study of Health in Pomerania ,Cohort ,Female ,business ,030217 neurology & neurosurgery ,All cause mortality ,Demography ,Follow-Up Studies - Abstract
Objective Alexithymia is associated with various mental as well as physical disorders. Some evidence also suggested high alexithymia to increase mortality risk, but these results are few and based on specific sample compositions. We aimed to investigate the impact of alexithymia on mortality risk in a large population based cohort. In addition, we sought to elucidate the effects of the subfactors of alexithymia and sex differences. Methods In a sample of N = 1380 individuals from the Study of Health in Pomerania (SHIP), we investigated the hazard-ratio (HR) of alexithymia as obtained by the Toronto Alexithymia Scale-20 (TAS-20) on all-cause mortality over an average observation time of 10 years. Sex-by-TAS-20-interactions as well as sex-stratified analyses were performed. Results Alexithymia was significantly associated with enhanced mortality risk (HR = 1.033; 95%-CI = 1.008–1.058); p = 0.009). While sex-by-TAS-20 interactions remained insignificant, sex-stratified analyses showed that this effect was only significant in men (HR = 1.050; 95%-CI = 1.022–1.079; p ≤ 0.001), but not in women (HR: 1.008; 95%-CI = 0.960–1.057; p = 0.76). The effect was validated for the “difficulties identifying feelings” (DIF) and “difficulties describing feelings” (DDF) subfactors of the TAS-20. Conclusion Our study supports and extents previous findings by indicating that mortality risk enhancing effects of alexithymia are specific to male subjects and validated for the DIF and DDF facets. Socioeconomic, clinical and metabolic factors were associated with this relationship. Finding that the impact of alexithymia remains stable in the fully adjusted models suggests that yet unidentified additional factors must be considered.
- Published
- 2021